|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 401/14 | (2006.01) |
| C07D 401/04 | (2006.01) | ||
| C07D 403/10 | (2006.01) | ||
| C07D 213/82 | (2006.01) | ||
| A61K 31/4439 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2861579 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13730652.8 |
| Date of filing the European patent application | 2013-05-09 | |
| (97) | Date of publication of the European application | 2015-04-22 |
| (45) | Date of publication and mention of the grant of the patent | 2018-02-21 |
| (46) | Date of publication of the claims translation | 2018-05-10 |
| (86) | Number | PCT/IB2013/053768 |
| Date | 2013-05-09 |
| (87) | Number | WO 2013/171639 |
| Date | 2013-11-21 |
| (30) | Number | Date | Country code |
| 201261647174 P | 2012-05-15 | US | |
| 201361790967 P | 2013-03-15 | US |
| (72) |
DODD, Stephanie Kay, US
FURET, Pascal, CH
GROTZFELD, Robert Martin, CH
JONES, Darryl Brynley, CH
MANLEY, Paul, CH
MARZINZIK, Andreas, CH
PELLE, Xavier Francois Andre, CH
SALEM, Bahaa, CH
SCHOEPFER, Joseph, CH
JAHNKE, Wolfgang, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Benzamido dariniai, skirti ABL1, ABL2 ir BCR-ABL1 aktyvumo inhibavimui |
| BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1 |
| Payment date | Validity (years) | Amount | |
| 2025-04-22 | 13 | 289.00 EUR |
| 2026-05-09 |